Antiviral Drug Development and Treatment Strategies, Including Vaccination

Outbreaks of influenza happen each year and regularly achieve pandemic levels at some part of the season. Antiviral medications are a second line of protection framework against flu contamination. Antiviral drugs are suggested for both treatment and avoidance of influenza. Antiviral medications work best when taken inside 48 hours of onset of influenza side effects, yet they may in any case offer advantages when taken later. These solutions may diminish the length of influenza by one to two days and avoid extreme influenza intricacies. The antiviral medications have been affirmed for treatment of intense uncomplicated flu and for some preventive employments. Tamiflu (oseltamivir phosphate), Relenza (zanamivir) and Rapivab (peramivir) are the three FDA-affirmed flu antiviral medications suggested by CDC for use against as of late coursing flu infections. The impact of particular antiviral procedures in genuine or life-debilitating flu is not set up from clinical trials directed to bolster licensure of oral oseltamivir, breathed in zanamivir, or intravenous peramivir.

  • Novel antiviral therapies for influenza and other respiratory viruses
  • Antiviral therapeutics and advancement in antiviral drug delivery
  • Novel antiviral agents in advanced development
  • Adjuvant and immune-modulatory therapies
  • Effectiveness of antivirals

Related Conference of Antiviral Drug Development and Treatment Strategies, Including Vaccination

May 11-12, 2017

4th International congress on Infectious Diseases

Barcelona, Spain
August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 04-05, 2017

Global Experts Meeting on Sexually Transmitted Diseases

Macau, Hong Kong
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
Sep 25-26, 2017

2nd International Conference on Infection Control

Chicago, Illinois, USA
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA

Antiviral Drug Development and Treatment Strategies, Including Vaccination Conference Speakers

Recommended Sessions

Related Journals

Are you interested in